TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician's choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769) Meeting Abstract

  

Authors:	Traina, T. A.; Chen, Y.; Khoury, K.; Rugo, H. S.; Mayer, E. L.; Abdou, Y.; Melisko, M. E.; Pareja, F.; Weigelt, B.; Chandarlapaty, S.; Turner, N. C.; Lang, J. M.; Sharifi, M. N.; Conzen, S. D.; Nanda, R.
Abstract Title:	TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician's choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769)
Meeting Title:	2025 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	43
Issue:	16 Suppl.
Meeting Dates:	2025 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2025-06-01
Start Page:	TPS1142
Language:	English
ACCESSION:	WOS:001509495900001
DOI:	10.1200/JCO.2025.43.16_suppl.TPS1142
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/227107